Investing in Growth, Enabling Change
English      中文

Arsenal Capital Partners is a progressive private equity firm that
facilitates transformational growth and change through a
collaborative approach.

News

Arsenal announces sale of Certara, retains significant minority investment stake

New York, July 11, 2017 – Arsenal Capital Partners (“Arsenal”) today announced that it has agreed to sell its portfolio company, Certara (the “Company”), the leading provider of technology-driven decision support solutions for drug development, to EQT VII Fund for an enterprise value of $850 million. As part of the transaction, Arsenal Capital Partners will retain a minority ownership stake in Certara. The...

Arsenal Capital Partners Completes Sale Of Flowchem To KMG

NEW YORK, June 15, 2017 - Arsenal Capital Partners (“Arsenal”) today completed the previously announced sale of its portfolio company Flowchem ("Flowchem" or the "Company"), a leading manufacturer of pipeline performance products, to KMG (NYSE: KMG), a global provider of specialty chemicals, for $495 million.

Founded in 2001 and based in Waller, Texas, Flowchem is a leading global provider of drag-reducing additives (“DRA”), related...

Arsenal Capital Partners Announces Promotion of Joe Rooney to Principal

Robbie Cahill and Andrew Hudelson Promoted to Senior Associate

NEW YORK, May 9, 2017 — Arsenal Capital Partners, a leading New York based private equity firm that specializes in investments in specialty chemicals and materials, and healthcare services companies, today announced the promotion of Joe Rooney to Principal. In addition, Robbie Cahill and Andrew Hudelson have been promoted to Senior Associate.

Terry Mullen, Arsenal Co-Founder and Partner, commented, “Over the past 17 years we have worked to build a leading institution in...

KMG to Acquire Flowchem LLC

FORT WORTH, Texas—(GLOBE NEWSWIRE)—April 24, 2017—KMG (NYSE: KMG), a global provider of specialty chemicals, today announced it has signed a definitive agreement to acquire Flowchem, a leading manufacturer of pipeline performance products, from Arsenal Capital Partners (Arsenal). 

Founded in 2001 and based in Waller, Texas, Flowchem is a leading global provider of drag-reducing agents, related support services and equipment to midstream crude oil and refined...

Accella agrees to purchase spray polyurethane foam business from Covestro

Expands core product and technology offering in spray foam Insulation and roofing markets

ST LOUIS MO - February 17, 2017 - Accella Polyurethane Systems LLC (“Accella”) has agreed to purchase certain assets of the North American spray polyurethane foam (SPF) business from Covestro LLC. The sale is scheduled to be completed by April 1, 2017. Financial terms have not been disclosed.

“This acquisition will significantly improve Accella’s position in the spray polyurethane foam market and is another strategic step with our positive...

Arsenal Capital Partners Names Joseph M. Salley as Specialty Industrials Operating Partner

Salley Most Recently Served as Chief Executive Officer of Milliken & Company

NEW YORK, January 24, 2017 — Arsenal Capital Partners, a leading New York based private equity firm that invests in middle market specialty industrials and healthcare companies, announced today that it has expanded its team with the addition of Joseph M. Salley, former Chief Executive Officer of Milliken & Company, as an Operating Partner working within the firm’s Specialty Industrials Group.

Dr. Salley served with Milliken & Company for 20 years, holding a...

Mouse over text to stop rotation
Copyright © 2005 - 2017 Arsenal Capital Partners. All rights reserved.             Disclaimer